Researchers are excited about this new drug, a novel dual compound showing promising data in early trials for weight loss . It works by modulating both pathways : GLP-1 and GIP, that , when stimulated, support control hunger and boost energy expenditure . Early reports demonstrate substantial size reduction and likely benefits for patients dealing